Thymic carcinoma overview

Thymic Carcinoma Microchapters
Home
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Thymic carcinoma from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
Staging
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
Chest X Ray
Echocardiograph and Ultrasound
CT
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Future or Investigational Therapies
Case Studies
Case #1
Thymic carcinoma overview On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Google Images
American Roentgen Ray Society Images of Thymic carcinoma overview All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Thymic carcinoma overview
CDC on Thymic carcinoma overview
Thymic carcinoma overview in the news
Blogs on Thymic carcinoma overview
Directions to Hospitals Treating Type page name here
Risk calculators and risk factors for Thymic carcinoma overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Alejandro Lemor, M.D. [2]

Overview

Thymic carcinoma, also known as type C thymoma, is a rare condition (less than 0.13/100,000/year) but should be included in the differential diagnosis of anterior mediastinic masses. It is a tumor of the thymic epithelium, like thymoma, but it is associated with lack of immature lymphocytes and often presents with more invasive or metastatic disease.

Thymic carcinomas can metastasize, generally to pleura, kidney, bone, liver or brain